Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
193,828,463
-
Total 13F shares
-
117,300,177
-
Share change
-
+4,418,396
-
Total reported value
-
$3,824,660,106
-
Put/Call ratio
-
2.4%
-
Price per share
-
$32.61
-
Number of holders
-
114
-
Value change
-
+$145,729,688
-
Number of buys
-
72
-
Number of sells
-
32
Institutional Holders of BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) as of Q2 2020
As of 30 Jun 2020 BridgeBio Pharma, Inc. - Common Stock, par value $0.001 per share (BBIO) had 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 117,300,177 shares of stock of the company.
Largest 10 holders included Kohlberg Kravis Roberts & Co. L.P., VIKING GLOBAL INVESTORS LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, AMERICAN INTERNATIONAL GROUP INC, BlackRock Inc., HILLHOUSE CAPITAL ADVISORS, LTD., Aisling Capital Management LP, STATE STREET CORP, and Cormorant Asset Management, LP.
This table shows 114 institutional shareholders of the security as of 30 Jun 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.